Skip to content

Clinical trials

COVID-19 trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Chile Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202031
202117
20223
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status12
Terminated7
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pontificia Universidad Catolica de Chile13
University of Chile8
AstraZeneca2
CanSino Biologics Inc.2
Merck Sharp & Dohme LLC2
Universidad Nacional Andres Bello2
Universidad de Magallanes2
Universidad del Desarrollo2
Amgen1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1954
Anxiety Disorders4
Coronavirus Infections4
Severe Acute Respiratory Syndrome3
Critical Illness2
Respiratory Aspiration2
Acute Lung Injury1
Ataxia1
Cognition Disorders1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.